Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,505 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06703606RecruitingPhase 1
Switching from Emicizumab to Marstacimab for Severe Hemophilia A
This study tests if switching from emicizumab to a new medicine called marstacimab is safe and effective for people with severe hemophilia A. You must have been on emicizumab for at least 6 months and not have a history of blood clots or heart disease.
Los Angeles, CaliforniaAges 12–74 - NCT07243184Recruiting
Polymer heart valve study for mitral valve disease
This trial is testing a new polymer artificial heart valve for people with severe mitral valve problems. It aims to see if this valve is safe and works well during surgical replacement.
BeijingAges 60 years+ - NCT07269210RecruitingPhase 2
Solbinsiran for severe high triglycerides
This study tests a new medicine called solbinsiran (LY3561774) for people with very high triglyceride levels. It aims to see if it can lower these fats in your blood and reduce the risk of pancreatitis or heart problems.
Phoenix, ArizonaAges 18 years+ - NCT07201311RecruitingPhase 2
Stomach decontamination for severe poisoning in the ICU
This trial tests whether giving activated charcoal plus emptying the stomach can help people who are on a breathing machine after severe poisoning. It may lower the amount of poison in the body and improve recovery.
ParisAges 18 years+ - NCT07001800RecruitingPhase 2/Phase 3
Slowing aortic valve disease with ataciguat
This trial tests a new pill, ataciguat, to slow down the progression of moderate calcific aortic valve stenosis (a condition where your aortic valve stiffens). If you have moderate valve narrowing and meet the other criteria, participation could help find a way to delay needing surgery.
Birmingham, AlabamaAges 50 years+ - NCT06724315Recruiting
Studying severe COPD in Brazil
This study follows people with severe or very severe COPD to learn more about their health over time. You may qualify if your COPD causes many symptoms or frequent flare-ups.
São Paulo, São PauloAges 18 years+ - NCT06734520Recruiting
Super transplant for severe beta-thalassemia
This trial tests a special type of stem cell transplant (called a super transplant) for children with a severe form of beta-thalassemia. It may be an option if you cannot or choose not to have a standard stem cell transplant or gene therapy.
Guangzhou, GuangdongAges 7–10 - NCT06743711Recruiting
Heart fitness in severe mental illness study
This study checks how fit your heart and lungs are if you have a serious mental illness like schizophrenia or bipolar disorder. It aims to see if fitness can help improve health and well-being.
Glostrup MunicipalityAges 18–45 - NCT06751836Recruiting
New ways to treat severe dengue
This trial tests new strategies to treat dengue, ranging from mild to severe cases. It may help people with different stages of dengue find better care and support.
Guatemala CityAges 18 years+ - NCT06789380Recruiting
Generalist vs specialist care for severe personality disorders
This trial compares two types of treatment—generalist care by a therapist or specialist care—for people with severe personality disorders. It aims to find which approach works better and is more cost-effective.
Halsteren, North BrabantAges 18 years+ - NCT06790875Recruiting
Comparing two ventilator settings for lung health in ARDS
This study tests two methods of adjusting a ventilator to see which one may better protect the lungs of patients with ARDS. It will help doctors learn how to set the machine to reduce strain on the lungs.
Wuhan, HubeiAges 18–80 - NCT06805409Recruiting
Ultrasound test for kidney risk in ARDS patients
This study tests whether a special ultrasound of the veins (VExUS) can help predict kidney injury in people with severe breathing problems who are on a breathing machine and receiving medicine to support their blood pressure.
Créteil, Val de MarneAges 18–100 - NCT06809868Recruiting
Study of genetic elements in sepsis and aging
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
San Francisco, CaliforniaAges 18 years+ - NCT06851156Recruiting
Brain stimulation for disorders of consciousness after severe injury
This trial tests a new type of brain stimulation called transcranial temporal interference stimulation to see if it can help people with severe brain injury who are in a vegetative or minimally conscious state. It uses gentle electrical currents to try to improve awareness and recovery.
Xi'an, ShaanxiAges 18–65 - NCT06867120Recruiting
Predicting pancreatitis severity with bowel sounds
This study uses a special device to listen to bowel sounds to help predict how severe acute pancreatitis will be. The goal is to find a simple, non-invasive way to guide treatment.
Beijing, Beijing MunicipalityAges 18–85 - NCT06895837Recruiting
Exercise and appetite study for men
This study looks at how exercise affects appetite when eating fewer calories. It may help men who want to understand how their body responds to diet and exercise.
GlasgowAges 18–65 - NCT06903780Recruiting
Survey on biologic treatments for severe asthma
This study surveys patients who have been on a biologic treatment for severe asthma for at least 6 months but not longer than 18 months. It aims to understand their experience, including those who did not respond well to the treatment.
Exeter, DevonAges 18 years+ - NCT06904079Recruiting
AI-based rehab study for serious mental disorders
This study uses computer analysis and AI to predict how people with severe mental disorders might recover and to suggest better support. It may help improve rehabilitation plans tailored to each person.
ShanghaiAges 18–65 - NCT06914622Recruiting
Real-life recovery study for mental health
This study uses a smartphone app to track daily experiences, physical activity, and biological markers in people receiving treatment for a mental disorder. The goal is to understand how these factors relate to personal recovery.
BresciaAges 18 years+ - NCT06967207Recruiting
Electrical imaging lung monitor for ARDS outcomes
This study tests if a special imaging technique (Electrical Impedance Tomography or EIT) can help doctors better predict outcomes in people with severe lung injury (ARDS). The goal is to use regular, safe lung scans to guide breathing treatment.
Guangzhou, GuangdongAges 18–80 - NCT06968559RecruitingPhase 3
Early steroid treatment for severe burns
This study tests whether giving a steroid called dexamethasone early after a severe burn can reduce serious complications and the risk of death. It is for adults on a breathing machine with large burns.
Chambray-lès-ToursAges 18–80 - NCT07029828RecruitingPhase 3
Long-term study of ritlecitinib for severe alopecia areata in children
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
Encinitas, CaliforniaAges 6–14 - NCT07085923Recruiting
Heart health study for people with mental illness
This study tests a program to improve heart health in people with schizophrenia or bipolar disorder who take antipsychotic medication or lithium and have a high body weight. The goal is to help reduce heart disease risk.
OsloAges 25–70 - NCT07091279RecruitingPhase 2
Test of Propranolol for Severe Behaviors in Autism
This study tests a medication called propranolol to see if it can reduce aggression and other severe behaviors in adolescents and adults with autism. It might be an option if you have frequent and serious challenging behaviors that other treatments haven't helped.
Staten Island, New YorkAges 12–40
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,505 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.